Related Experiment Video
Updated: Jun 29, 2026
Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
The radiotherapy clinical trials projects at the ESRF: technical aspects
M Renier1, Th Brochard, C Nemoz
1European Synchrotron Radiation Facility, BP 220, F-38043 Grenoble, France. renier@srf.fr
Major upgrades are needed for the ESRF ID17 Biomedical beamline to support advanced radiotherapy clinical trials for aggressive brain tumors, including Stereotactic Synchrotron Radiation Therapy (SSRT) and Microbeam Radiation Therapy (MRT). These involve new constructions and system enhancements to improve patient positioning and accommodate increased X-ray flux.
Area of Science:
- Medical physics
- Radiotherapy research
- Biomedical engineering
Background:
- The ESRF ID17 Biomedical beamline is undergoing significant modifications to facilitate advanced radiotherapy clinical trials.
- These trials focus on treating aggressive brain tumors using novel techniques.
Purpose of the Study:
- To detail the necessary modifications and new constructions for the ESRF ID17 Biomedical beamline.
- To outline the implementation of Stereotactic Synchrotron Radiation Therapy (SSRT) and Microbeam Radiation Therapy (MRT) clinical trials.
- To present the project's organization and planning for beamline upgrades.
Main Methods:
- Upgrading the patient positioning system for accurate patient translation and rotation during SSRT.
- Constructing a new white beam hutch with a dedicated patient positioning system for MRT.
- Refurbishing existing control hutches and installations.
- Redesigning optical components to manage increased power from a second X-ray source.
Main Results:
- The modifications will enable precise patient positioning for SSRT treatments.
- A new hutch and system will be established for MRT clinical trials.
- Enhanced photon flux will be available due to the new X-ray source, requiring optical component redesign.
- The beamline will be prepared for advanced radiotherapy applications.
Conclusions:
- The ESRF ID17 Biomedical beamline is being significantly upgraded to support cutting-edge radiotherapy clinical trials.
- These enhancements are crucial for advancing the treatment of aggressive brain tumors using SSRT and MRT techniques.
- The project involves substantial construction, system refurbishment, and optical component redesign to optimize beamline performance and capacity.
